Kelvin Wu

Title: Innovations in Eye Movement Disorder Treatment by Kelvin Wu

Introduction

Kelvin Wu is an innovative inventor based in Seattle, WA (US). He has made significant contributions to the field of ocular mobility through his groundbreaking patent. His work focuses on developing non-invasive treatments for eye movement disorders, particularly acquired pendular nystagmus.

Latest Patents

Kelvin Wu holds a patent for an "Acquired Pendular Nystagmus Treatment Device." This device is designed to treat eye movement disorders in a non-invasive and non-pharmacologic manner. It is wearable and utilizes servo-controlled prisms to address disorders of ocular mobility. The device features an eye movement sensor and oscillates the image perceived by the patient in sync with pathological nystagmus, effectively negating its harmful effects. Importantly, the device only targets abnormal eye movements, allowing voluntary and normal reflex eye movements to function without interference. In addition to treating acquired pendular nystagmus, the device has potential applications for other ocular mobility disorders, including jerk nystagmus, strabismus, and vestibular insufficiency.

Career Highlights

Throughout his career, Kelvin Wu has demonstrated a commitment to advancing medical technology. His innovative approach to treating eye movement disorders has positioned him as a notable figure in the field. With a focus on non-invasive solutions, he continues to explore new avenues for improving patient outcomes.

Collaborations

Kelvin has collaborated with esteemed colleagues, including Bennett Curtis Burke and John S Stahl. Their combined expertise has contributed to the development and refinement of his innovative treatment device.

Conclusion

Kelvin Wu's contributions to the treatment of eye movement disorders exemplify the power of innovation in healthcare. His patented device represents a significant advancement in non-invasive treatment options, offering hope to those affected by ocular mobility disorders.